Eton Pharmaceuticals Inc
NASDAQ:ETON

Watchlist Manager
Eton Pharmaceuticals Inc Logo
Eton Pharmaceuticals Inc
NASDAQ:ETON
Watchlist
Price: 10.41 USD -1.79% Market Closed
Market Cap: 269m USD
Have any thoughts about
Eton Pharmaceuticals Inc?
Write Note

Eton Pharmaceuticals Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Eton Pharmaceuticals Inc
Operating Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Eton Pharmaceuticals Inc
NASDAQ:ETON
Operating Income
-$6.3m
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Operating Income
$24.2B
CAGR 3-Years
-1%
CAGR 5-Years
7%
CAGR 10-Years
1%
Bristol-Myers Squibb Co
NYSE:BMY
Operating Income
$11.1B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
13%
Pfizer Inc
NYSE:PFE
Operating Income
$13.1B
CAGR 3-Years
-17%
CAGR 5-Years
63%
CAGR 10-Years
-2%
Merck & Co Inc
NYSE:MRK
Operating Income
$21.7B
CAGR 3-Years
20%
CAGR 5-Years
10%
CAGR 10-Years
10%
Eli Lilly and Co
NYSE:LLY
Operating Income
$14.4B
CAGR 3-Years
25%
CAGR 5-Years
21%
CAGR 10-Years
15%

See Also

What is Eton Pharmaceuticals Inc's Operating Income?
Operating Income
-6.3m USD

Based on the financial report for Jun 30, 2024, Eton Pharmaceuticals Inc's Operating Income amounts to -6.3m USD.

What is Eton Pharmaceuticals Inc's Operating Income growth rate?
Operating Income CAGR 5Y
17%

Over the last year, the Operating Income growth was -65%. The average annual Operating Income growth rates for Eton Pharmaceuticals Inc have been 16% over the past three years , 17% over the past five years .

Back to Top